Pharma Excipients

News on Pharma Excipients

ExcipientFest Americas becomes Excipient World

17. July 2018 In May 2018 IPEC-Americas acquired ExcipientFest Americas and re-branded it "Excipient World". According to the organizers "Excipient World will continue the tradition of producing high quality…

Excipients Inside June 2018 – IPEC Europe

16. July 2018 Dear readers, It’s hard to believe that we’re issuing our June publication already and we find ourselves heading for the summer break. And of course, we’re now preparing for those mid-year reviews to…

Glatt TwinPro® – the Fusion of two Batch Processes

14. June 2018 The brand new Glatt TwinPro® is absolutely revolutionary. It combines two previously single batch processes into one single process: High Shear Granulation and Fluidized Bed Drying. Critical…

Selecting Excipients for Liquid-Filled Hard Capsules

Thixotropic gels, thermosoftened systems, and self-emulsifying systems have expanded the range of potential excipients. Liquid-filled hard capsules (LFHCs) are typically composed of a shell of gelatin or hydroxypropyl…

Excipient standards – Ask an Expert

13. July 2018 Q: What standards should my excipient supplier meet for excipient quality?   A: Jim Morris, NSF Health Sciences, a division of NSF International says: Historically,…

Preventing Film Coating Problems by Design

"Common defects in tablet film coating can be minimized by effective design of the tablet core and the coating process." Stuart C. Porter in Pharmaceutical Technology Film coatings on pharmaceutical tablets provide a broad range of…

Excipients: Kano Analysis and Quality by Design

07. July 2018 “If formulation science is the Cinderella of drug development, then excipients are the Cinderellas of formulation science”. R. C. Moreton, Finn Brit Consulting This chapter assumes some…

Dosing challenges in respiratory therapies

07. July 2018 The pulmonary route of administration has been commonly used for local lung conditions such as asthma and chronic obstructive pulmonary disease (COPD). Recently, with the advent of new…

The Broken Antibiotics Business Model Part II

05. July 2018 In part I of this series, I wrote about the financial unsustainability of antibiotics development. Revenues and profits of the new therapies launched since 2010 do not match the costs of…